Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Nordic Journal of Psychiatry|November 15, 2019
Improving quality of antipsychotic polypharmacy: a pilot studyHanne Høilund, David P Galea, Petter Andreas RingenFrontiers in Psychiatry|October 14, 2014
Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventionsPetter Andreas Ringen, John A Engh, Astrid B Birkenaes, et al.Frontiers in Psychiatry|September 26, 2019
Predictors for Antipsychotic Dosage Change in the First Year of Treatment in Schizophrenia Spectrum and Bipolar DisordersPetter Andreas Ringen, Elina Johanna Reponen, Trude Seselie Jahr Vedal, et al.Psychiatry Research|November 23, 2013
Indications of a dose-response relationship between cannabis use and age at onset in bipolar disorderTrine Vik Lagerberg, Levi Røstad Kvitland, Sofie R Aminoff, et al.Journal of the American College of Cardiology|August 25, 2022
Severe Mental Illness and Cardiovascular Disease: JACC State-of-the-Art ReviewMichael Goldfarb, Marc De Hert, Johan Detraux, et al.BMC Psychiatry|February 6, 2015
Continued cannabis use at one year follow up is associated with elevated mood and lower global functioning in bipolar I disorderLevi Roestad Kvitland, Ingrid Melle, Sofie Ragnhild Aminoff, et al.Journal of the International Neuropsychological Society : JINS|February 20, 2008
Emotion perception and learning potential: mediators between neurocognition and social problem-solving in schizophrenia?Anja Vaskinn, Kjetil Sundet, Svein Friis, et al.Comprehensive Psychiatry|November 23, 2013
One year follow-up of alcohol and illicit substance use in first-episode psychosis: does gender matter?Elisabeth Heffermehl Lange, Ragnar Nesvåg, Petter Andreas Ringen, et al.Psychiatry Research|November 6, 2016
Duration of untreated illness in first-treatment bipolar I disorder in relation to clinical outcome and cannabis useLevi Røstad Kvitland, Petter Andreas Ringen, Sofie Ragnhild Aminoff, et al.Pageof 4